Category icon
APSC Consensus Recommendations on High-risk Chronic Coronary Syndrome

Jack Wei Chieh Tan, Derek P Chew, David Brieger, et al

Category icon
The ISCHEMIA Trial: What is the Message for the Interventionalist?

Emmanuel Ako, Sukhjinder Nijjer, Abtehale Al-Hussaini, et al

Category icon
ACC 2021 Discussion: The STRENGTH Study

Steven E Nissen, Harriette Van Spall

Category icon
Inflammation and Cardiovascular Disease: The Future

Natalie Arnold, Katharina Lechner, Christoph Waldeyer, et al

Category icon
Rheumatoid Arthritis and Atherosclerotic Cardiovascular Disease

Anne Mirjam Kerola, Silvia Rollefstad, Anne Grete Semb,

Category icon
Dyslipidaemia in the Real World

Ricardo Lopez Santi, Felipe Martínez, Adrian Baranchuk, et al

Category icon
Inflammation in Coronary Epicardial and Microvascular Dysfunction

Shigeo Godo, Jun Takahashi, Satoshi Yasuda, et al

Category icon
Editorial: The EXCEL Trial

Pablo Avanzas, Juan Carlos Kaski,

About

Coronary artery disease (CAD) is one of the most common causes of death worldwide. It is responsible for one-third of deaths in people over 35 years old, with the percentage reaching close to 50% (according to some estimates) in western countries.

The existing treatment is medical, surgical or a combination of both depending on the extent, severity and clinical presentation of CAD & .There has been significant progress made in developing novel strategies for patients suffering from CAD and its associated complications. These strategies have ranged from drugs to robotic surgery to nanotechnology.

Related Articles

Articles

APSC Consensus Recommendations on High-risk Chronic Coronary Syndrome

Jack Wei Chieh Tan, Derek P Chew, David Brieger,

Published:

Citation: European Cardiology Review 2021;16:e26.

The ISCHEMIA Trial: What is the Message for the Interventionalist?

Emmanuel Ako, Sukhjinder Nijjer, Abtehale Al-Hussaini,

Published:

Citation: European Cardiology Review 2021;16:e24.

Trial Update: FORECAST, COMBINE OCT-FFR and DEFINE-PCI

Kevin Cheng, Ranil de Silva,

Published:

Citation: European Cardiology Review 2021;16:e22.

Inflammation and Cardiovascular Disease: The Future

Natalie Arnold, Katharina Lechner, Christoph Waldeyer,

Published:

Citation: European Cardiology Review 2021;16:e20.